Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
4(31%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
8%
Ph early_phase_1
1
8%
Ph not_applicable
11
85%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 1Safety & dosage
1(7.7%)
N/ANon-phased studies
11(84.6%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

13

all time

Status Distribution
Active(6)
Completed(5)
Other(2)

Detailed Status

Completed5
Recruiting2
Active, not recruiting2
unknown2
Enrolling by invitation1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
4
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (7.7%)
Phase 11 (7.7%)
N/A11 (84.6%)

Trials by Status

completed538%
enrolling_by_invitation18%
recruiting215%
active_not_recruiting215%
not_yet_recruiting18%
unknown215%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13